NDAORALTABLET
Approved
May 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
MINASTRIN 24 FE (ethinyl estradiol; norethindrone acetate) by Dr. Reddy's Laboratories. Approved for pregnancy. First approved in 2013.
Drug data last refreshed 26m ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MINASTRIN 24 FE is an oral combined hormonal contraceptive containing ethinyl estradiol and norethindrone acetate, approved by the FDA in 2013. It prevents pregnancy through estrogen and progestin receptor agonism, suppressing ovulation and altering cervical mucus. The product is currently in peak commercial lifecycle as a mature oral contraceptive.
$0.029BPart D
PeakProduct is at peak revenue with modest Part D penetration; brand team likely maintains established commercial infrastructure focused on patient retention and physician relationships.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
Working on MINASTRIN 24 FE offers exposure to mature contraceptive market dynamics, payer negotiations, and lifecycle management strategies in a high-volume, consumer-sensitive category. Career progression focuses on defensive market share retention, patient compliance programs, and managed care negotiations rather than new indication development.
Brand Manager
Worked on MINASTRIN 24 FE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.